Navigation Links
Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
Date:2/23/2009

Cross Corporation and Mundipharma International Holdings Ltd. validate its scientific foundation and the utility of its product candidates. For more information, please visit the Company's Web site at www.biocryst.com.

Forward-looking statements

This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include that our belief that many subjects in the Phase 2 clinical trials of peramivir did not receive adequate dosing by intramuscular injection may not be correct, that HHS and the Food & Drug Administration (FDA) may not agree with our analysis, that HHS may further condition, reduce or eliminate future funding of the peramivir program, that ongoing peramivir clinical trials may not be successful, that the peramivir program may not be successful, that the pivotal trial with forodesine HCl in cutaneous T-cell lymphoma (CTCL) may not meet its endpoint, that development and commercialization of forodesine HCl in CTCL may not be successful, that we or our licensees may not be able to enroll the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed, that BioCryst or its licensees may not commence as expected additio
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
2. Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor
3. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
4. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
5. Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinsons Disease
6. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
7. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
8. Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results
9. Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
10. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
11. Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015  When Ryan Rendino first ... of his neck, he figured it was ... weeks off from weight lifting. ... A series of doctor ... to Michel Kliot, MD , a ...
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6csvbs/market_assessment ... "Market Assessment of Respiratory Diagnostics in the United ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service provides ... in the United States ... provides detailed analysis of the current and forecasted ...
(Date:5/21/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today that its Board of ... second quarter 2015 of $0.03 per share of common ... share will be paid on June 19, 2015 to ... 2015.  The ex-dividend date for the quarterly dividend is ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4United States and Europe Respiratory Diagnostics Market Assessment 2015 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... PARSIPPANY, N.J., March 8, 2011 Pacira Pharmaceuticals, Inc. (Nasdaq: ... announced that David Stack, president and chief executive officer, is ... Conference on Thursday, March 17, 2011, at 9:30 a.m. EDT ... Mr. Stack is expected to present an overview of the ...
... 2011 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... President and Chief Executive Officer, will present at the ... the Boston Marriott Copley Place.  The presentation is scheduled ...
Cached Medicine Technology:AcelRx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference 2
(Date:5/24/2015)... The Rolling Stones Zip Code ... Diego at Petco Park. This iconic group is ready ... 20th, they had a warmup show in Los Angeles at ... Los Angeles, this beloved band not only played their Sticky ... such as "Jumping Jack Flash," "Moonlight Mile" and "All ...
(Date:5/24/2015)... 2015 Scientists with Cardno ChemRisk, a ... quality compliance issues that may have raised the risk ... has just posted an article on the research. ... group found airborne asbestos levels well above OSHA safety ... and 2011. , “Asbestos compliance sampling data associated with ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Inc. (MTA) has selected IFN as a fiber transport ... Sales Manager, fiber route diversity and network redundancy are ... MTA with the diverse fiber transport from their Merrillville ... voice carriers located at Henry Street in Indianapolis, IN. ...
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers ... Florida City exactly five years to the day after the ... A large fire tore through the Branches United Methodist Church ... the middle of the night as neighbors, staff and Branches' ... even though it is suspected that the fire began accidentally. ...
(Date:5/23/2015)... 2015 On Wednesday, May 20, 2015, ... has been the target of a sophisticated cyberattack,” and ... company’s ongoing Information Technology (IT) security efforts in the ... The most notable attack on health insurers was reported ... nation’s second largest health insurer, revealed that they had ...
Breaking Medicine News(10 mins):Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... (Nasdaq: DYNT ) today announced the election of ... filled the vacancy created by the,recent passing of long-time ... is a principal of NightWatch Capital, a mid-sized,value-oriented hedge ... for,Harvest Earnings, an operations improvement consulting firm for banks ...
... Angeles Jewish Home,the largest single-source provider of senior housing ... past president of Jewish Big,Brothers of Los Angeles David ... 1. Newly elected to the board were Marshall A. ... Arthur A. Greenberg in the Home,s top volunteer,leadership spot, ...
... 31 Lupin Pharmaceuticals, Inc. (LPI),announced today ... the Company,s,Abbreviated New Drug Application (ANDA) for ... and 500 mg from the U.S. Food ... product have,already commenced., Lupin,s Divalproex sodium ...
... part of its continued effort to give back to ... annual scientific meeting, the Fairfax, Va.-based American Society for ... Kenneth B. Schwartz Center to raise awareness of cancer ... to educate, train and support caregivers in the art ...
... over $2 million in conducting the company,s prosthetic heart valve clinical ... TEMPO research platform , ... Research Triangle Park, NC ... software company, today announces that On-X Life Technologies has saved over ...
... of Public Health Confirms Positive Review ... of DNA ... it received a formal letter from the California Department of Public,Health (CDPH) ... letter states that DNA Direct,s tests are,performed only with a physician order ...
Cached Medicine News:Health News:Dynatronics Elects Mark A. Crockett to its Board of Directors 2Health News:Los Angeles Jewish Home Selects Community Volunteer David Swartz as its Board of Directors' Chair 2Health News:Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets 2Health News:On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace 2Health News:On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace 3Health News:On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace 4Health News:DNA Direct Confirms It Is Operating in Compliance with California State Laboratory Law 2
Short double-horn bridge for insertion of instruments...
Only SurLok combines precise control, enhanced basket and grasper strength, and the added security of a unique wire-locking mechanism. You can feel the difference. The SurLok flat-wire and grasper ha...
... Tip 12 Inch , 20 inch,PVC, Length ... Available in 3,4,5 6Fr. These top quality ... flexible polymer material and have standard screw ... They are manufactured to the highest standards. ...
... SILASTIC Brand Latex Foley Catheter, ... calcification build-up, Firm, but flexible, latex-based ... Medium length - round tip with ... balloon (336xx) or two staggered eyes ...
Medicine Products: